StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
1404
Publishing Date
2022 - 03 - 15
10
2022 - 01 - 18
9
2022 - 01 - 05
9
2021 - 12 - 16
10
2021 - 12 - 14
11
2021 - 12 - 13
10
2021 - 12 - 10
7
2021 - 12 - 06
17
2021 - 12 - 01
9
2021 - 11 - 29
9
2021 - 11 - 15
10
2021 - 10 - 27
8
2021 - 10 - 21
7
2021 - 10 - 13
7
2021 - 10 - 04
9
2021 - 09 - 29
9
2021 - 09 - 28
12
2021 - 09 - 27
8
2021 - 09 - 22
8
2021 - 09 - 20
8
2021 - 09 - 15
8
2021 - 09 - 13
13
2021 - 09 - 09
12
2021 - 09 - 08
8
2021 - 09 - 01
7
2021 - 07 - 22
8
2021 - 07 - 19
7
2021 - 07 - 06
7
2021 - 06 - 30
12
2021 - 06 - 29
11
2021 - 06 - 28
11
2021 - 06 - 24
10
2021 - 06 - 23
10
2021 - 06 - 22
8
2021 - 06 - 21
7
2021 - 06 - 16
10
2021 - 06 - 11
10
2021 - 06 - 10
7
2021 - 06 - 09
9
2021 - 06 - 08
12
2021 - 06 - 07
12
2021 - 06 - 04
7
2021 - 05 - 20
8
2021 - 05 - 19
8
2021 - 05 - 12
8
2021 - 04 - 29
9
2021 - 04 - 21
7
2021 - 04 - 12
7
2021 - 04 - 06
9
2021 - 03 - 22
7
2021 - 03 - 16
8
2021 - 03 - 15
8
2021 - 02 - 25
8
2021 - 02 - 17
7
2021 - 02 - 04
7
2021 - 01 - 25
7
2020 - 12 - 17
8
2020 - 12 - 15
10
2020 - 12 - 09
6
2020 - 12 - 07
9
Sector
Administrative and support and waste management and remediation services
1
Commercial services
19
Communications
3
Consumer services
5
Distribution services
7
Electronic technology
5
Energy minerals
1
Finance
16
Health care and social assistance
1
Health services
14
Health technology
1134
Industrial services
7
Manufacturing
89
Mining, quarrying, and oil and gas extraction
8
Miscellaneous
2
N/a
5
Non-energy minerals
8
Process industries
8
Producer manufacturing
2
Professional, scientific, and technical services
39
Technology services
5
Transportation and warehousing
1
Utilities
2
Tags
Acquisition
4244
Application
1781
Approval
1706
Awards
1448
Cancer
2823
Ceo
1673
Ces
4255
Collaboration
1769
Conference
14983
Contract
1510
Corporation
2443
Covid
2680
Covid-19
1834
Deadline
2004
Disease
1876
Distribution
2193
Drug
1968
Earnings
2846
Energy
4959
Europe
1748
Ev
1455
Events
3801
Fda
2323
Financial
2690
Financial results
8251
For
13399
Global
3929
Group
2282
Growth
7981
Health
3351
Iot
1741
Liver
1420
Market
11412
Media
1478
N/a
175064
Nasdaq
1892
Offering
5394
Partnership
1815
People
2010
Pharm-country
1493
Pharma
1536
Phase 2
1404
Platform
1415
Positive
2067
Presentation
2330
Program
2337
Report
8352
Research
7223
Results
26522
Sales
1567
Services
1445
System
1713
Technology
4147
Test
2086
Therapeutics
4901
Therapy
2201
Treatment
3622
Trial
5127
Update
1528
Vaccine
1617
Entities
Acurx pharmaceuticals llc
6
Akero therapeutics, inc.
7
Algernon pharmaceuticals inc.
10
Alnylam pharmaceuticals, inc.
8
Altimmune, inc.
7
Amgen inc.
12
Anaptysbio, inc.
6
Anavex life sciences corp.
10
Angion biomedica corp
7
Aptinyx inc.
6
Arrowhead pharmaceuticals, inc.
12
Athira pharma, inc.
7
Atossa therapeutics, inc.
7
Ayala pharmaceuticals, inc.
7
Azurrx biopharma, inc.
10
Biogen inc.
9
Biophytis - adr
7
Bridgebio pharma, inc.
6
Bristol-myers squibb company
9
Clene inc
12
Curevac n.v.
9
Denali therapeutics inc.
6
Dynavax technologies corporation
10
Eli lilly and company
23
Eloxx pharmaceuticals, inc.
8
Entera bio ltd.
8
Evelo biosciences, inc.
6
G1 therapeutics, inc.
7
Galecto, inc.
7
Gilead sciences, inc.
8
Histogen inc.
6
Humanigen, inc.
6
I-mab
21
Ideaya biosciences, inc.
9
Immunic, inc.
7
Immunitybio inc
11
Incyte corporation
11
Infinity pharmaceuticals, inc.
6
Johnson & johnson
19
Kintara therapeutics, inc.
7
Longeveron llc - class a
11
Mediwound ltd.
11
Merck & company, inc.
6
Metacrine, inc.
9
Moderna, inc.
12
Nantkwest, inc.
7
Ocuphire pharma inc.
9
Onconova therapeutics, inc.
7
Otonomy, inc.
6
Pds biotechnology corporation
12
Pfizer, inc.
10
Protagonist therapeutics, inc.
8
Redhill biopharma ltd.
14
Rubius therapeutics, inc.
6
Sanofi
22
Scholar rock holding corporation
6
Sorrento therapeutics, inc.
16
Springworks therapeutics, inc.
6
Todos medical ltd.
6
Vir biotechnology, inc.
7
Symbols
ACXP
6
AGNPF
10
AKRO
7
ALNY
8
ALT
7
AMGN
12
ANAB
6
ANGN
7
APTX
6
ARWR
12
ASND
7
ATHA
7
ATOS
7
AVXL
10
AYLA
7
AZRX
10
BBIO
6
BIIB
9
BMY
9
BPTS
7
CLNN
12
CVAC
9
DNLI
6
DVAX
10
ELOX
8
ENTX
8
EVLO
6
GILD
8
GLTO
7
GTHX
7
HGEN
6
HSTO
6
IBRX
11
IDYA
9
IMAB
21
IMUX
7
INCY
11
INFI
6
JNJ
19
KTRA
7
LGVN
11
LLY
23
MDWD
11
MRK
6
MRNA
12
MTCR
9
NK
7
OCUP
9
ONTX
7
ORPH
6
OTIC
6
PDSB
12
PFE
10
PTGX
8
RARE
6
RDHL
14
SNY
22
SNYNF
7
SRNE
16
VIR
7
Exchanges
Amex
28
Lse
14
Nasdaq
1287
Nyse
121
Tsx
14
Crawled Date
2022 - 03 - 15
10
2022 - 01 - 18
8
2022 - 01 - 05
8
2021 - 12 - 16
10
2021 - 12 - 14
11
2021 - 12 - 13
10
2021 - 12 - 10
8
2021 - 12 - 06
17
2021 - 12 - 01
9
2021 - 11 - 29
9
2021 - 11 - 15
10
2021 - 10 - 27
8
2021 - 10 - 04
10
2021 - 09 - 29
9
2021 - 09 - 28
12
2021 - 09 - 27
8
2021 - 09 - 22
8
2021 - 09 - 20
8
2021 - 09 - 15
8
2021 - 09 - 13
13
2021 - 09 - 09
12
2021 - 09 - 08
8
2021 - 07 - 22
7
2021 - 07 - 19
7
2021 - 07 - 06
7
2021 - 06 - 30
12
2021 - 06 - 29
11
2021 - 06 - 28
11
2021 - 06 - 24
10
2021 - 06 - 23
10
2021 - 06 - 22
8
2021 - 06 - 21
7
2021 - 06 - 16
10
2021 - 06 - 11
10
2021 - 06 - 10
7
2021 - 06 - 09
10
2021 - 06 - 08
11
2021 - 06 - 07
12
2021 - 06 - 04
7
2021 - 05 - 20
8
2021 - 05 - 19
8
2021 - 05 - 12
8
2021 - 04 - 29
8
2021 - 04 - 21
7
2021 - 04 - 20
7
2021 - 04 - 12
7
2021 - 04 - 06
9
2021 - 03 - 22
8
2021 - 03 - 16
9
2021 - 03 - 15
9
2021 - 02 - 25
9
2021 - 02 - 17
7
2021 - 02 - 04
8
2021 - 01 - 25
7
2020 - 12 - 17
12
2020 - 12 - 15
9
2020 - 12 - 11
9
2020 - 12 - 07
9
2020 - 12 - 03
10
2020 - 12 - 01
12
Crawled Time
00:00
22
00:20
6
01:00
16
02:00
2
03:00
2
05:00
7
06:00
16
07:00
22
08:00
8
09:00
7
10:00
6
11:00
53
11:01
2
12:00
228
12:01
9
12:03
15
12:11
2
12:15
59
12:20
6
12:30
29
12:39
2
13:00
150
13:01
8
13:02
3
13:03
9
13:04
2
13:05
4
13:11
2
13:15
41
13:26
2
13:30
49
13:35
7
14:00
120
14:01
8
14:03
3
14:05
2
14:15
17
14:28
2
14:30
17
14:47
2
15:00
86
15:15
2
15:25
2
15:30
12
15:56
2
16:00
31
16:20
12
17:00
21
18:00
31
18:16
4
19:00
22
20:00
29
20:20
4
21:00
39
21:02
3
21:03
3
22:00
52
22:01
4
22:15
3
23:00
22
Source
aimimmuno.com
1
alteritytherapeutics.com
1
investor.aveooncology.com
1
ir.akerotx.com
3
ir.anaptysbio.com
2
ir.cyclerion.com
2
ir.kalvista.com
3
ir.stockpr.com
1
ir.vaccinex.com
1
ir.vtvtherapeutics.com
2
jaguarhealth.gcs-web.com
2
nouveaumonde.ca
2
ocutx.gcs-web.com
1
www.achievelifesciences.com
1
www.affimed.com
1
www.agtc.com
2
www.akerotx.com
1
www.alnylam.com
2
www.anaptysbio.com
1
www.anavex.com
3
www.athira.com
3
www.atossatherapeutics.com
2
www.ayalapharma.com
1
www.beyondspringpharma.com
1
www.biospace.com
778
www.celyad.com
1
www.clarivate.com
2
www.cortexyme.com
2
www.crinetics.com
2
www.curevac.com
5
www.cytomx.com
1
www.eagleus.com
1
www.eyegatepharma.com
1
www.globenewswire.com
456
www.hillintl.com
1
www.igcinc.us
5
www.immunic-therapeutics.com
2
www.immunogen.com
1
www.janone.com
2
www.metacrine.com
1
www.nantkwest.com
6
www.oramed.com
1
www.poseida.com
3
www.prnewswire.com
83
www.rubiustx.com
1
www.sutrobio.com
2
www.vbivaccines.com
5
www.zynerba.com
2
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Phase 2
save search
MediWound Announces Last Patient Out in EscharEx U.S. Phase 2 Trial for the Debridement of Chronic Wounds
Published:
2022-03-21
(Crawled : 13:30)
- biospace.com/
MDWD
2 d
|
$13.99
-0.14%
-0.14%
110K
|
Health Technology
|
585.2%
|
O:
2.04%
H:
0.5%
C:
-3.5%
phase 2
ces
trial
Athira Pharma Presents Study Overview and Baseline Data from ACT-AD Phase 2 Trial of Fosgonimeton in Mild-to-Moderate Alzheimer’s Disease at the 2022 AD/PD™ Congress
Published:
2022-03-20
(Crawled : 12:20)
- globenewswire.com
ATHA
A
|
$3.715
-2.24%
-2.29%
290K
|
Health Technology
|
Email alert
Add to watchlist
alzheimer
phase 2
trial
disease
alzheimer’s
alzheimer's disease
alzheimer's
act-ad phase 2
fosgonimeton
PICCOLO: A Phase 2, Single Arm Study of Mirvetuximab Soravtansine in Recurrent, Platinum-Sensitive, High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers with High Folate Receptor Alpha Expression
Published:
2022-03-19
(Crawled : 00:20)
- immunogen.com
IMGN
|
$4.67
-5.08%
-5.35%
2M
|
Health Technology
|
Email alert
Add to watchlist
phase 2
one
cancer
mirvetuximab
Recursion Announces Enrollment of First Patient in Phase 2 Trial for the Treatment of Cerebral Cavernous Malformation
Published:
2022-03-18
(Crawled : 12:30)
- biospace.com/
RXRX
P
|
$9.67
3.2%
3.1%
1.3M
|
Professional, Scientific, and T...
|
35.4%
|
O:
0.0%
H:
7.95%
C:
3.61%
treatment
phase 2
ces
trial
enroll
rec-994
Ionis announces publication of positive Phase 2 data for donidalorsen in New England Journal of Medicine
Published:
2022-03-16
(Crawled : 00:00)
- prnewswire.com
IONS
S
|
$40.94
-0.63%
-0.64%
590K
|
Health Technology
|
21.25%
|
O:
-0.15%
H:
2.62%
C:
2.45%
phase 2
pos
positive
Oramed Completes Patient Enrollment in Phase 2 Oral Insulin NASH Trial
Published:
2022-03-16
(Crawled : 13:00)
- biospace.com/
ORMP
|
$2.06
0.0%
1.2M
|
Health Technology
|
-76.78%
|
O:
2.48%
H:
4.79%
C:
4.29%
phase 2
trial
enroll
insulin
nash
Ocuphire Completes Enrollment of Over 100 Subjects in 24-Week ZETA-1 Phase 2b Trial of Oral APX3330 for the Treatment of Diabetic Retinopathy
Published:
2022-03-16
(Crawled : 12:00)
- globenewswire.com
OCUP
|
$3.53
0.86%
0.85%
69K
|
Health Technology
|
5.11%
|
O:
0.6%
H:
3.28%
C:
0.9%
apx3330
treatment
phase 2
phase 2b
trial
100
diabetic
enroll
diabetes
Protagonist Therapeutics Earns $25 Million Milestone Payment from Janssen Biotech for Dosing of Third Patient in Phase 2b Clinical Trial of PN-235 in Moderate-to-Severe Plaque Psoriasis
Published:
2022-03-16
(Crawled : 12:00)
- biospace.com/
PTGX
4
|
$14.33
-0.9%
-0.91%
650K
|
Health Technology
|
-44.0%
|
O:
2.01%
H:
1.1%
C:
0.57%
pn-235
phase 2
phase 2b
trial
therapeutics
psoriasis
one
biotech
iot
milestone
plague
U.K. Competition and Markets Authority to Refer Merger to a Phase 2 Review
Published:
2022-03-16
(Crawled : 08:00)
- prnewswire.com
NLOK
|
$21.62
0.19%
|
Technology Services
|
-28.06%
|
O:
-3.39%
H:
0.69%
C:
-10.24%
phase 2
merge
Windtree Completes Enrollment of Phase 2 Study of Istaroxime in Early Cardiogenic ShockOn track for top-line data in April 2022
Published:
2022-03-15
(Crawled : 20:00)
- biospace.com/
WINT
|
$0.1694
2.11%
2.07%
880K
|
Health Technology
|
-82.36%
|
O:
2.07%
H:
4.17%
C:
-0.52%
phase 2
top-line data
cardio
star
enroll
topline
Revelation Biosciences Inc. Announces Enrollment and Dosing Complete for Phase 2b Viral Challenge Study to Assess Efficacy of Intranasal REVTx 99 for the Prevention of H3N2 Influenza Infection
Published:
2022-03-15
(Crawled : 13:30)
- biospace.com/
REVB
|
$9.12
8.83%
8.11%
180K
|
|
721.57%
|
O:
9.8%
H:
63.39%
C:
11.61%
phase 2
phase 2b
bioscience
infection
influenza
enroll
infections
MAIA Biotechnology, Inc. Announces HREC Approval in Australia for its THIO-101 Phase 2 Trial for NSCLC
Published:
2022-03-15
(Crawled : 13:30)
- biospace.com/
SNYNF
|
News
|
$98.55
0
|
Health Technology
|
-4.25%
|
O:
-3.03%
H:
3.21%
C:
3.21%
SNY
|
News
|
$46.02
-2.58%
-2.65%
3.5M
|
Health Technology
|
-7.97%
|
O:
3.07%
H:
0.0%
C:
0.0%
thio-101
phase 2
technology
trial
approval
australia
biotech
iot
Alector Presents AL001 (latozinemab) Data from the FTD-C9orf72 Cohort of the INFRONT-2 Phase 2 Clinical Trial
Published:
2022-03-15
(Crawled : 12:30)
- globenewswire.com
ALEC
M
|
$9.51
-0.52%
-0.53%
630K
|
Health Technology
|
-32.2%
|
O:
1.85%
H:
1.38%
C:
-5.38%
al001
ema
phase 2
trial
Arrowhead Files for Regulatory Clearance to Initiate Phase 1/2a Study of ARO-RAGE for Treatment of Asthma
Published:
2022-03-15
(Crawled : 12:30)
- biospace.com/
ARWR
|
$36.76
-0.68%
-0.68%
610K
|
Health Technology
|
-6.59%
|
O:
1.89%
H:
2.65%
C:
0.87%
treatment
clearance
phase 1
phase 2
Trevi Therapeutics Concludes Enrollment for Phase 2 CANAL Trial in IPF Chronic Cough
Published:
2022-03-15
(Crawled : 12:00)
- prnewswire.com
TRVI
|
$2.965
5.89%
5.56%
130K
|
Health Technology
|
112.12%
|
O:
2.27%
H:
14.07%
C:
8.15%
phase 2
trial
therapeutics
chronic cough
enroll
Anavex Life Sciences Announces Presentation of Phase 2 Clinical Biomarker Data from ANAVEX®2-73-PDD-001 Parkinson’s Disease Dementia Study at AD/PD™ 2022 International Conference
Published:
2022-03-15
(Crawled : 12:00)
- biospace.com/
AVXL
|
$11.27
-0.88%
-0.89%
1.1M
|
Health Technology
|
10.81%
|
O:
0.4%
H:
6.32%
C:
5.24%
pdd-001
anavex
phase 2
dementia
anavex®2-73
parkinson
conference
presentation
disease
life science
international
tiona
biomarkers
Sage Therapeutics Announces Presentation of Encouraging Results from the Phase 2 PARADIGM Study (Part A) of SAGE-718 in Patients with Mild Cognitive Impairment due to Parkinson’s Disease
Published:
2022-03-15
(Crawled : 12:00)
- biospace.com/
SAGE
|
$44.2
-0.88%
-0.88%
400K
|
Health Technology
|
45.2%
|
O:
1.07%
H:
2.93%
C:
1.06%
sage-718
phase 2
air
parkinson
therapeutics
presentation
disease
results
PDS Biotech Announces Achievement of an Enrollment Objective in National Cancer Institute-Led Phase 2 Clinical Trial of PDS0101-Based Combination in Advanced HPV-Associated Cancers
Published:
2022-03-15
(Crawled : 12:00)
- globenewswire.com
PDSB
|
$8.59
-1.83%
-1.86%
350K
|
Health Technology
|
72.24%
|
O:
0.2%
H:
7.86%
C:
7.27%
pds0101
phase 2
ces
hpv
trial
cancer
biotech
iot
tiona
enroll
IDEAYA Biosciences Reports IDE397 Interim Phase 1 Clinical Data
Published:
2022-03-15
(Crawled : 12:00)
- biospace.com/
IDYA
|
$17.58
-0.17%
-0.17%
390K
|
Health Technology
|
35.36%
|
O:
-6.99%
H:
9.17%
C:
-1.74%
ide397
idea
phase 1
report
bioscience
phase 2
phase 3
AnaptysBio Reports Imsidolimab ACORN Phase 2 Clinical Trial Data in Moderate-to-Severe Acne
Published:
2022-03-14
(Crawled : 22:00)
- biospace.com/
ANAB
|
$25.82
-3.15%
-3.25%
160K
|
Health Technology
|
-12.85%
|
O:
0.31%
H:
2.23%
C:
-0.97%
phase 2
trial
acne
report
← Previous
1
2
3
4
5
6
7
8
9
…
70
71
Next →
Gainers vs Losers
62%
38%
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.